Status:

COMPLETED

Pharmacotoxicology of Trichloroethylene Metabolites

Lead Sponsor:

University of Florida

Conditions:

Congenital Lactic Acidosis

Eligibility:

All Genders

21-50 years

Phase:

NA

Brief Summary

To establish the relationship between human MAAI haplotype and DCA and tyrosine metabolism. This aim test the postulates that MAAI haplotype determines, and thus can predict,1) dose-dependent DCA kine...

Detailed Description

The arms of the study involves determining the haplotype of individuals enrolled. Then participants were divided into two groups based on their genotype. The groups include a genotype with an EGT alle...

Eligibility Criteria

Inclusion

  • Healthy volunteers

Exclusion

  • Pregnancy
  • Other medications
  • Psychiatric illness on meds
  • Abnormal labs

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2012

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00874276

Start Date

August 1 2009

End Date

November 1 2012

Last Update

June 4 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida Shands Hospital

Gainesville, Florida, United States, 32610